Remove 2019 Remove Clinical Practice Remove Healthcare Professional Remove Screening
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Stacy: We’re using anxiety, baseline anxiety, as our screening.

article thumbnail

The importance of social connection: Julianne Holt-Lunstad, Thomas Cudjoe, & Carla Perissinotto

GeriPal

Ashwin Kotwal: Yeah, and Thomas, I know this is something we’ve talked about as a group too, which is how do you translate some of these scales that we use in large studies to our clinical practice? Thomas: But the person did screen and used a little bit of the and Social Network Scale and the UCLA Loneliness Scale.

IT 100